Efficacy and toxicity of therapy immediately after treatment with nivolumab in relapsed multiple myeloma.

Authors

Matthew J Pianko
Samuel A Funt
David B Page, Providence Cancer Center, Earle A. Chiles Research Institute Portland , OR , USAFollow
Deepika Cattry
Emma C Scott
Stephen M Ansell
Ivan M Borrello
Martin Gutierrez
Nikoletta Lendvai
Hani Hassoun
C Ola Landgren
Alexander M Lesokhin

Document Type

Article

Publication Date

1-1-2018

Publication Title

Leukemia & lymphoma

Keywords

Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Immunological/adverse effects; Antineoplastic Agents, Immunological/therapeutic use; Combined Modality Therapy/methods; Female; Humans; Male; Middle Aged; Multiple Myeloma/drug therapy; Multiple Myeloma/pathology; Neoplasm Recurrence, Local; Nivolumab/adverse effects; Nivolumab/therapeutic use; Remission Induction; Treatment Outcome

Clinical Institute

Cancer

Department

Oncology

Department

Earle A. Chiles Research Institute

Recommended Citation

Pianko, Matthew J; Funt, Samuel A; Page, David B; Cattry, Deepika; Scott, Emma C; Ansell, Stephen M; Borrello, Ivan M; Gutierrez, Martin; Lendvai, Nikoletta; Hassoun, Hani; Landgren, C Ola; and Lesokhin, Alexander M, "Efficacy and toxicity of therapy immediately after treatment with nivolumab in relapsed multiple myeloma." (2018). Articles, Abstracts, and Reports. 73.
https://digitalcommons.providence.org/publications/73